Kymera Therapeutics to Participate in Upcoming June Investor Conferences

WATERTOWN, Mass., May 29, 2024 -- Kymera Therapeutics, Inc. , a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation , today...

Related Keywords

Miami ,Florida ,United States ,Watertown ,New York ,Boston ,Massachusetts ,Justine Koenigsberg ,Nasdaq ,Goldman Sachs ,Kymera Therapeutics Inc ,Healthcare Conference ,Annual Global Healthcare Conference ,Media Contact ,